Optain key facts
- Developer of retinal imaging technology designed to offer noninvasive diagnosis of eye and systemic health conditions in real time.
- It has raised $37.0M; the latest was Later Stage VC ($25.0M) in Sep 2025.
- Notable investors include Insight Partners (New York), UPMC Enterprises, Informed Ventures, Novant Health, University of Pittsburgh Medical Center — 14 tracked in total.
- Status: Privately Held (backing).
Who backs Optain
14+- ·The complete investor list: 14 names
- ·Watch Optain: the Monday email on marks, rounds and moves
Optain funding rounds
No funding rounds for Optain are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
Optain investors
14 investors are on record for Optain, including Insight Partners (New York), UPMC Enterprises, Informed Ventures and Novant Health.
About Optain
Developer of retinal imaging technology designed to offer noninvasive diagnosis of eye and systemic health conditions in real time. The company's technology empowers people with artificial intelligence and automation, using the eye as the gateway to detect and prevent diseases in their early stages, enabling medical doctors to accurately identify the early signs of various eye conditions.
- Sector
- Healthcare
- HQ
- Chadstone, Australia
- Founded
- 2019
- Website
- optainhealth.com/
- Ownership
- Privately Held (backing)
Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.
Optain doesn't have a valuation on record yet — one is published once a priced round, a reported valuation, fund marks, or secondary prints surface in our sources. The rest of the record below builds toward it.